Overview

With the fastest growing economy and being one of the advanced pharmaceutical and healthcare systems in the region, the Kingdom of Bahrain is a welcoming destination for medicinal products and medical device manufacturers. The National Health Regulatory Authority (NHRA) oversees product / device registrations and respective regulatory procedures. Though the region recognizes certifications from international renowned Regulatory bodies, navigating through demanding obligations might require thorough knowledge on the market.

Freyr, as a proven Regulatory affair consulting partner, assists foreign manufacturers to decode the Regulatory nuances of the Bahrain region and streamlines Regulatory activities for in-time approvals. Freyr’s Regulatory services in Bahrain span across:

  • Medical Devices
  • Drugs
  • Cosmetics
  • Food and Supplements
  • Consumer Healthcare Products

Freyr Capabilities

  • Strategic Regulatory Consulting
  • Regulatory Affairs & Regulatory intelligence
  • Registration pathways and license management services
  • New drug application, License renewals
  • eCTD submissions
  • Preparation of dossiers for the registration of medicines

Freyr Advantages

  • Strategic and well-versed local regulatory knowledgebase – NHRA
  • Regulatory team with proven global RA expertise
  • Proactive and Collaborative approach
  • Quick turnarounds and faster time-to-market
  • Keeping abreast with region-specific legislation and Regulatory guidelines